Spectrophotometric intracutaneous analysis versus dermoscopy for the diagnosis of pigmented skin lesions: prospective, double-blind study in a secondary reference centre

Melanoma Research

Volumn 19, Issue 3, 2009, Pages 176-179

  Glud, Martin ^a,c   Gniadecki, Robert ^b   Drzewiecki, Krzysztof T ^a  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DOUBLE BLIND PROCEDURE; EPILUMINESCENCE MICROSCOPY; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SKIN DEFECT; SPECTROPHOTOMETRIC INTRACUTANEOUS ANALYSIS; SPECTROPHOTOMETRY; TRAINING; ADOLESCENT; COMPARATIVE STUDY; MIDDLE AGED; PATHOLOGY; SKIN TUMOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DERMOSCOPY; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS; SPECTROPHOTOMETRY; YOUNG ADULT;

EID: 67849128648     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/CMR.0b013e328322fe5f     Document Type: Article

References (16)

1. De Vries E, Bray FI, Coebergh JWW, Parkin DM, for the European Network of Cancer Registries. Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality but recent stabilizations in Western Europe and decreases in Scandinavia. Int J Cancer 2003; 107:117-126.
2. Danish Cancer Registry. Year report 2002. Copenhagen: National Board of Health; 2004.
3. Beddingfield FC 3rd. The melanoma epidemic: res ipsa loquitur. Oncologist 2003; 8:459-465.
4. Kittler H, Pehamberger H, Wolff K, Binder M. Diagnostic accuracy of dermoscopy. Lancet Oncol 2002; 3:159-165.
5. Bafounta ML, Beauchet A, Aegerter P, Saiag P. Is dermoscopy (epiluminescence microscopy) useful for the diagnosis of melanoma? Results of a meta-analysis using techniques adapted to the evaluation of diagnostic tests. Arch Dermatol 2001; 137:1343-1350.
6. Giblin AV, Thomas JM. Incidence, mortality and survival in cutaneous melanoma. J Plast Reconstr Aesthetic Surg 2007; 60:32-40.
7. Thompson JF, Scoyler RA, Kefford RF. Cutaneous melanoma. Lancet 2005; 365:687-701.
8. Charles CA, Yee VS, Dusza SW, Marqhoob AA, Oliveria SA, Kopf A, et al. Variation in the diagnosis, treatment, and management of melanoma in situ: a survey of US dermatologist. Arch Dermatol 2005; 141:723-729.
9. Marghoob AA, Swindle LD, Moricz CZM, Sanchez FA, Slue B, Halpern AC, et al. Instruments and new technologies for the in vivo diagnosis of melanoma. J Am Acad Dermatol 2003; 49:777-797.
10. Claridges E, Cotton S, Hall P, Moncrieff M. From colour to tissue histology: physics-based interpretation of images of pigmented skin lesions. Med Image Anal 2003; 7:489-502.
11. Moncrieff M, Cotton S, Claridges E, Hall P. Spectrophotometric intracutaneous analysis: a new technique for imaging pigmented skin lesions. Br J Dermatol 2002; 146:448-457.
12. Govindan K, Smith J, Knowles L, Harvey A, Townsend P, Kenealy J. Assesment of nurse-led screening of pigmented lesions using SIAscope. J Plast Reconstr Aesthetic Surg 2007; 60:639-645.
13. Balch CM, Buzaid CA, Soong S-J, Atkins MB, Cascinelli N, Coit DG, et al. Final version of the American Joint Committee on cancer staging system for cutaneous melanoma. J Clin Oncol 2001; 19:3635-3648.
14. Altman DG. Practical statistics for medical research. London: Chapman & Hall; 1991.
15. GraphPad Software: QuickCalcs online calculator for scientists (available at website http://www.graphpad.com).
16. Haniffa MA, Lloyd JJ, Lawrence CM. The use of a spectrophotometric intracutaneous analysis device in the real-time diagnosis of melanoma in the setting of a melanoma screening clinic. Br J Dermatol 2007; 156: 1350-1352.